A Bay Area biotech company saw its obesity drug fail in clinical trials just five months ago. Now it's being acquired for nearly $7 billion after shifting its focus to a different disease.
MP Bradley Thomas has urged residents to use the towns Post Office counter in TG Jones on Bromsgrove High Street after it was saved from closure.
From startup to a potential $2.2 billion buyout within a year: How a big deal could pay off for patients, a young company and ...
OX Security reported a phishing campaign targeting developers using OpenClaw's name to lure victims into a fake site for ...
Gadget Review on MSN
Out of 500+ tools, 13 no-code AI tools will make you $1M
No-code AI tools can generate $1M revenue streams by automating workflows and building apps without expensive developers or ...
Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity could help reduce risk of addiction to substances like cannabis, alcohol, and cocaine. The corresponding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results